On October 30, 2024, AstraZeneca disclosed that its International Executive Vice President and China President, Leon Wang, was under investigation by Chinese Authorities. On this news, AstraZeneca ...
A class action lawsuit was filed against AstraZeneca Plc (AZN) by Levi & Korsinsky on December 23, 2024. The plaintiffs ...
Wilson Encourages Investors Who Suffered Losses In AstraZenecaTo Contact Him Directly To Discuss Their Options If you purchased or acquired securities in AstraZeneca between ...
The situation escalated with the arrest of Leon Wang, AstraZeneca’s Executive Vice President International and China President. This development, coupled with internal forecasts predicting a ...
AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...
The Anglo-Swedish pharmaceutical giant AstraZeneca faces mounting pressure from shareholders regarding ongoing investigations in China, one of its key markets. The concerns emerged after the detention ...
The head of AstraZeneca's Chinese operations has been ... In a brief statement, AZ confirmed that Leon Wang, who is also executive vice president, international, at the pharma group, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results